Avricore Health Inc
XTSX:AVCR

Watchlist Manager
Avricore Health Inc Logo
Avricore Health Inc
XTSX:AVCR
Watchlist
Price: 0.06 CAD -7.69% Market Closed
Market Cap: CA$6.1m

Avricore Health Inc
Other Operating Expenses

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Avricore Health Inc
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Avricore Health Inc
XTSX:AVCR
Other Operating Expenses
-CA$8.1k
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotricity Inc
NASDAQ:BTCY
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
CardioComm Solutions Inc
XTSX:EKG
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Diagnos Inc
XTSX:ADK
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
NetraMark Holdings Inc
CNSX:AIAI
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Avricore Health Inc
Glance View

Market Cap
6.1m CAD
Industry
Health Care

Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies (POCT). The firm's flagship offering includes HealthTab. HealthTab is a point-of-care testing solution that combines point-of-care technologies with a cloud-based platform for global health issues. HealthTab offers a screening system, designed to support pharmacist role. The company enables the patients to be active about health by measuring and monitoring safety tests and biomarkers of chronic disease. Rapid Access Safety Test Reporting (RASTR), is a network is the point-of-care based system, which provides direct consumer consent on patient demographics, as well as real-time reporting on data. The firm's subsidiary includes Vanc Marine Pharmaceuticals Inc. and HealthTab Inc.

AVCR Intrinsic Value
0.04 CAD
Overvaluation 33%
Intrinsic Value
Price CA$0.06

See Also

What is Avricore Health Inc's Other Operating Expenses?
Other Operating Expenses
-8.1k CAD

Based on the financial report for Sep 30, 2025, Avricore Health Inc's Other Operating Expenses amounts to -8.1k CAD.

What is Avricore Health Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
-12%

Over the last year, the Other Operating Expenses growth was 22%. The average annual Other Operating Expenses growth rates for Avricore Health Inc have been -12% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett